Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Return on Sales (2017 - 2025)

Historic Return on Sales for Assembly Biosciences (ASMB) over the last 9 years, with Q3 2025 value amounting to 0.85%.

  • Assembly Biosciences' Return on Sales rose 5500.0% to 0.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.04%, marking a year-over-year increase of 4000.0%. This contributed to the annual value of 1.41% for FY2024, which is 71400.0% up from last year.
  • Assembly Biosciences' Return on Sales amounted to 0.85% in Q3 2025, which was up 5500.0% from 1.06% recorded in Q2 2025.
  • Assembly Biosciences' 5-year Return on Sales high stood at 0.84% for Q1 2021, and its period low was 21.17% during Q4 2021.
  • Its 5-year average for Return on Sales is 4.83%, with a median of 1.47% in 2023.
  • Its Return on Sales has fluctuated over the past 5 years, first skyrocketed by 168400bps in 2021, then crashed by -159800bps in 2022.
  • Over the past 5 years, Assembly Biosciences' Return on Sales (Quarter) stood at 21.17% in 2021, then surged by 38bps to 13.05% in 2022, then surged by 88bps to 1.53% in 2023, then rose by 8bps to 1.4% in 2024, then surged by 39bps to 0.85% in 2025.
  • Its Return on Sales stands at 0.85% for Q3 2025, versus 1.06% for Q2 2025 and 0.94% for Q1 2025.